- Home
- Publications
- Publication Search
- Publication Details
Title
Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas
Authors
Keywords
-
Journal
Immunotherapy
Volume 6, Issue 11, Pages 1187-1206
Publisher
Future Medicine Ltd
Online
2014-12-13
DOI
10.2217/imt.14.94
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
- (2014) Michinori Ogura et al. JOURNAL OF CLINICAL ONCOLOGY
- Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma
- (2013) Takashi Ishida et al. CANCER SCIENCE
- A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome
- (2013) E.C. Benton et al. EUROPEAN JOURNAL OF CANCER
- Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma
- (2013) Koji Kato et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
- (2013) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
- (2012) Hiroo Katsuya et al. JOURNAL OF CLINICAL ONCOLOGY
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
- (2012) D.-K. Chang et al. MOLECULAR CANCER THERAPEUTICS
- Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma
- (2011) Y. Sawada et al. BLOOD
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunopathogenesis of lymphoma: Focus on CCR4
- (2010) Takashi Ishida et al. CANCER SCIENCE
- Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
- (2010) T. Ishii et al. CLINICAL CANCER RESEARCH
- New Strategies in Peripheral T-Cell Lymphoma: Understanding Tumor Biology and Developing Novel Therapies
- (2010) K. Dunleavy et al. CLINICAL CANCER RESEARCH
- Targeted treatment and new agents in peripheral T-cell lymphoma
- (2010) Jasmine M. Zain et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Dosing of a Phase I Study of KW-0761, an Anti-CCR4 Antibody, for Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Ritsuro Suzuki JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Kazuhito Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Engineered therapeutic antibodies with improved effector functions
- (2009) Tsuguo Kubota et al. CANCER SCIENCE
- Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2R null Mice In Vivo
- (2009) A. Ito et al. JOURNAL OF IMMUNOLOGY
- Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome
- (2009) R. Takahashi et al. JOURNAL OF IMMUNOLOGY
- Evaluation of FoxP3 Expression in Peripheral T-Cell Lymphoma
- (2008) Irina Bonzheim et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions
- (2008) M. Ahmadzadeh et al. BLOOD
- Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF
- (2008) Hiroki Yano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
- (2008) Asahi Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Array Comparative Genomic Hybridization Analysis of PTCL-U Reveals a Distinct Subgroup with Genetic Alterations Similar to Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
- (2008) M. Nakagawa et al. CLINICAL CANCER RESEARCH
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
- (2008) Kunihiro Tsukasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma
- (2008) Kennosuke Karube et al. MODERN PATHOLOGY
- Orchestrating the orchestrators: chemokines in control of T cell traffic
- (2008) Shannon K Bromley et al. NATURE IMMUNOLOGY
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2008) Wen-Hung Chung et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now